Bgi Genomics (300676.SZ) traded flat 0 % during a 24 hours period ending at 10:08 PM Central Europe on Monday 26th. One Bgi Genomics stock can currently be bought for about CNY 40 on popular exchanges. Current supply of Bgi Genomics stocks is 383.8 mn. Bgi Genomics has a current market capitalization of CNY 15.6 bn and approximately CNY 491.5 mn worth of Bgi Genomics was traded on exchanges in the last 24 hours. Since last month end, Bgi Genomics has traded -10.15 % down. Simple moving average of last 200 days is at CNY 38.25. The highest price of past 52 weeks was recorded at CNY 65 on 01/13/2026. 52 weeks low was at CNY 32.55 on 06/11/2026.

Here is how related stocks have performed in the past 24 hours:

  • Jiangsu Lihua Foods (300761.SZ) traded flat 0 % and now trades at CNY 21.51. Current market capitalisation for Jiangsu Lihua Foods is CNY 18.5 bn. Jiangsu Lihua Foods has a current price to earnings ratio of 51.96.

  • Hmt Xiamen New Technical M (603306.SS) traded flat 0 % and now trades at CNY 55.2. Hmt Xiamen New Technical M has a market capitalisation of CNY 18.5 bn. Current price/earnings ratio for Hmt Xiamen New Technical M is 193.83.

  • Kunshan Kinglai Hygienic (300260.SZ) traded flat 0 % and now trades at CNY 43.74. Current market capitalisation for Kunshan Kinglai Hygienic is CNY 18.7 bn. Kunshan Kinglai Hygienic has a current price to earnings ratio of 109.55.

  • Shanghai Microport Medbot-h (2252.HK) traded flat 0 % and now trades at HKD 21.18. Shanghai Microport Medbot-h has a market capitalisation of HKD 21.8 bn.

  • Shanghai Athub (603881.SS) traded flat 0 % and now trades at CNY 21.14. Shanghai Athub has a market capitalisation of CNY 18.6 bn. Current price/earnings ratio for Shanghai Athub is 133.

About Bgi Genomics

BGI Genomics Co., Ltd. is a biotechnology company based in Shenzhen, China. It offers sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners, both nationally and internationally. The company specializes in providing DNA, RNA, and customized sequencing services; as well as non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services. Additionally, it offers clinical and research solutions for oncology. BGI Genomics Co., Ltd. has operations in various research areas such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company was previously known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. It was founded in 1999 and has its main office in Shenzhen, China. The company’s website is accessible under www.bgi.com , and it is listed on the Shenzhen Stock Exchange.